Based on our Pharmacor advisory service entitled Human Immunodeficiency Virus, Decision Resources is offering an exclusive analyst call entitled The Increasing Challenges of the Maturing HIV Drug Market: Will Gilead’s Quad or Merck’s Vicriviroc Be Able to Compete? Because this presentation features report updates, it is ONLY available to purchasers of this Pharmacor advisory service.

This analyst call was held on March 16, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.


Click here to view the invite.